[
  {
    "ts": null,
    "headline": "Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock.",
    "summary": "A secretive biotechnology-centered hedge fund bought shares of  Kymera Therapeutics  after the stock soared to its highest level on record.  A Form 4 filed with the Securities and Exchange Commission on Dec. 11 shows Baker Brothers Advisors bought just over 2 million shares of the biopharmaceutical company for roughly $172 million in two separate transactions that day.  Shares pulled back slightly from those levels before Baker Bros. swooped in on Thursday.",
    "url": "https://finnhub.io/api/news?id=b82f1fd35f1e807c6fc25723850ac8f4749565f77c6c227f584be41cfab46358",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765701000,
      "headline": "Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock.",
      "id": 137792762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "A secretive biotechnology-centered hedge fund bought shares of  Kymera Therapeutics  after the stock soared to its highest level on record.  A Form 4 filed with the Securities and Exchange Commission on Dec. 11 shows Baker Brothers Advisors bought just over 2 million shares of the biopharmaceutical company for roughly $172 million in two separate transactions that day.  Shares pulled back slightly from those levels before Baker Bros. swooped in on Thursday.",
      "url": "https://finnhub.io/api/news?id=b82f1fd35f1e807c6fc25723850ac8f4749565f77c6c227f584be41cfab46358"
    }
  }
]